Citadel Advisors »

Rapt Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $883k 34k 25.79
2025-06-30 $116k 14k 8.00

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Rapt Therapeutics

TCG Crossover Management
Foresite Capital Management VI
Rtw Investments
OrbiMed Advisors
Ikarian Capital
Boone Capital Management
Deep Track Capital
Vanguard Group
Nantahala Capital Management
Siren
Redmile Group
Soleus Capital Management
ADAR1 Capital Management
Fcpm Iii Services B.v.
Boothbay Fund Management

View all funds holding Rapt Therapeutics